|
KIAA0020 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.736600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.112840E-01 |
| Normal-vs-Stage2 |
9.299000E-01 |
| Normal-vs-Stage3 |
4.314400E-01 |
| Normal-vs-Stage4 |
5.301800E-01 |
| Stage1-vs-Stage2 |
3.192800E-01 |
| Stage1-vs-Stage3 |
3.769600E-02 |
| Stage1-vs-Stage4 |
2.450600E-01 |
| Stage2-vs-Stage3 |
6.162000E-01 |
| Stage2-vs-Stage4 |
6.992400E-01 |
| Stage3-vs-Stage4 |
9.695400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.123000E-01 |
| Normal-vs-AfricanAmerican |
6.512400E-01 |
| Normal-vs-Asian |
3.130200E-01 |
| Caucasian-vs-AfricanAmerican |
6.328000E-01 |
| Caucasian-vs-Asian |
1.470960E-01 |
| AfricanAmerican-vs-Asian |
3.499600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.225420E-01 |
| Normal-vs-Female |
3.093000E-01 |
| Male-vs-Female |
2.958800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.546800E-01 |
| Normal-vs-Extreme_Weight |
1.351440E-01 |
| Normal-vs-Obese |
7.964000E-01 |
| Normal-vs-Extreme_Obese |
4.826600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.552210E-01 |
| Normal_Weight-vs-Obese |
9.257600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.512800E-01 |
| Extreme_Weight-vs-Obese |
2.720600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.032600E-01 |
| Obese-vs-Extreme_Obese |
6.810600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.255820E-01 |
| Normal-vs-Age(41-60Yrs) |
5.633400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.709020E-01 |
| Normal-vs-Age(81-100Yrs) |
6.651800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.263800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.156000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.250300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.403400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.326980E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.859400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.664500E-02 |
| Normal-VS-Type2 PRCC |
4.504800E-01 |
| Normal-VS-KIRP CIMP |
2.888300E-02 |
| Normal-VS-Unclassified PRCC |
8.733200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.148950E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.197660E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.352200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.956260E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.028000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.552000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.369400E-01 |
| Normal-vs-N1 |
1.829050E-01 |
| Normal-vs-N2 |
3.074800E-01 |
| N0-vs-N1 |
7.487900E-02 |
| N0-vs-N2 |
6.278000E-01 |
| N1-vs-N2 |
2.209600E-02 |
|
|
